TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
PolyPid reported a quarterly loss of $0.41 per share for Q4 2025, falling short of the expected loss of $0.33 per share. This resulted in a negative surprise of 24.24%, reflecting challenges in the ...
New Market Briefing From Black Book Research Highlights 80% of Surveyed Hospitals Active in EHR Initiatives and Accelerating Demand for SATUSEHAT Interoperability Operations LONDON, GB / ACCESS ...
ATLANTA - Artivion, Inc. (NYSE:AORT), a $1.93 billion market cap medical device company whose shares have surged 31.86% over the past six months, announced new clinical data from two trials evaluating ...
Request for FDA Rolling Review submitted to FDA on January 30, 2026 Non-Clinical and CMC BLA modules submitted to FDA At FDA's request, Type D Meeting expected in March 2026 to review Comparative ...
At FDA's request, Type D Meeting expected in March 2026 to review Comparative Oncology biomarker data from patients treated in OST-HER2 Phase 2b human clinical trial and OST-HER2 trial in spontaneous ...
ATLANTA, Feb. 2, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new clinical data from ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...
In today’s digital world, audio content has become a crucial element of communication, learning, and entertainment. Podcasts, video narrations, online courses, and voice assistants all rely on voice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results